These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

668 related items for PubMed ID: 19061283

  • 1. Adjunctive human papillomavirus DNA testing is a useful option in some clinical settings for disease risk assessment and triage of females with ASC-H Papanicolaou test results.
    Bandyopadhyay S, Austin RM, Dabbs D, Zhao C.
    Arch Pathol Lab Med; 2008 Dec; 132(12):1874-81. PubMed ID: 19061283
    [Abstract] [Full Text] [Related]

  • 2. Reflex high-risk human papilloma virus DNA test is useful in the triage of women with atypical squamous cells cannot exclude high-grade squamous intraepithelial lesion.
    Wu HH, Allen SL, Kirkpatrick JL, Elsheikh TM.
    Diagn Cytopathol; 2006 Oct; 34(10):707-10. PubMed ID: 16955480
    [Abstract] [Full Text] [Related]

  • 3. Prevalence of high-risk human papillomavirus in women with abnormal and normal vaginal ThinPrep Papanicolaou cytology.
    Bansal M, Zhao C.
    J Low Genit Tract Dis; 2011 Apr; 15(2):105-9. PubMed ID: 21317806
    [Abstract] [Full Text] [Related]

  • 4. Significance of high-risk human papillomavirus DNA detection in women 50 years and older with squamous cell papanicolaou test abnormalities.
    Zhao C, Zhao S, Heider A, Austin RM.
    Arch Pathol Lab Med; 2010 Aug; 134(8):1130-5. PubMed ID: 20670132
    [Abstract] [Full Text] [Related]

  • 5. Human papillomavirus (HPV) testing in the management of women with abnormal Pap smears. Experience of a colposcopy referral clinic.
    Ciotti M, Sesti F, Paba P, Benedetto A, Patrizi L, Criscuolo A, Piccione E, Branca M, Syrjänen K, Favalli C.
    Eur J Gynaecol Oncol; 2004 Aug; 25(5):577-84. PubMed ID: 15493169
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.
    Kulasingam SL, Hughes JP, Kiviat NB, Mao C, Weiss NS, Kuypers JM, Koutsky LA.
    JAMA; 2002 Oct 09; 288(14):1749-57. PubMed ID: 12365959
    [Abstract] [Full Text] [Related]

  • 7. Use of a high-risk human papillomavirus DNA test as the primary test in a cervical cancer screening programme: a population-based cohort study.
    Zorzi M, Del Mistro A, Farruggio A, de'Bartolomeis L, Frayle-Salamanca H, Baboci L, Bertazzo A, Cocco P, Fedato C, Gennaro M, Marchi N, Penon MG, Cogo C, Ferro A.
    BJOG; 2013 Sep 09; 120(10):1260-7; discussion 1267-8. PubMed ID: 23786222
    [Abstract] [Full Text] [Related]

  • 8. Clinical performance of the aptima HPV assay in 4196 women with positive high-risk HPV and ASC-US cytology: A large women hospital experience.
    Wang T, Pradhan D, Zhang H, Matsko J, Zhao C.
    Diagn Cytopathol; 2021 Jan 09; 49(1):5-10. PubMed ID: 32857920
    [Abstract] [Full Text] [Related]

  • 9. Should women with atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion, receive reflex human papillomavirus-DNA testing?
    Liman AK, Giampoli EJ, Bonfiglio TA.
    Cancer; 2005 Dec 25; 105(6):457-60. PubMed ID: 16104044
    [Abstract] [Full Text] [Related]

  • 10. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.
    Manos MM, Kinney WK, Hurley LB, Sherman ME, Shieh-Ngai J, Kurman RJ, Ransley JE, Fetterman BJ, Hartinger JS, McIntosh KM, Pawlick GF, Hiatt RA.
    JAMA; 1999 May 05; 281(17):1605-10. PubMed ID: 10235153
    [Abstract] [Full Text] [Related]

  • 11. Immediate histopathologic follow-up of cervista and aptima high-risk HPV assays in women with LSIL cytology.
    Zhang H, Varma KR, Han M, Matsko J, Zhao C.
    Cancer Cytopathol; 2018 Aug 05; 126(8):525-532. PubMed ID: 29797678
    [Abstract] [Full Text] [Related]

  • 12. Prediction of cervical intraepithelial neoplasia grade 2+ (CIN2+) using HPV DNA testing after a diagnosis of atypical squamous cell of undetermined significance (ASC-US) in Catalonia, Spain.
    Ibáñez R, Moreno-Crespi J, Sardà M, Autonell J, Fibla M, Gutiérrez C, Lloveras B, Alejo M, Català I, Alameda F, Casas M, Bosch FX, de Sanjosé S.
    BMC Infect Dis; 2012 Jan 26; 12():25. PubMed ID: 22280073
    [Abstract] [Full Text] [Related]

  • 13. Human papillomavirus testing as triage for atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions: sensitivity, specificity, and cost-effectiveness.
    Kaufman RH, Adam E, Icenogle J, Reeves WC.
    Am J Obstet Gynecol; 1997 Oct 26; 177(4):930-6. PubMed ID: 9369847
    [Abstract] [Full Text] [Related]

  • 14. Reflex Human Papillomavirus Test Results as an Option for the Management of Korean Women With Atypical Squamous Cells Cannot Exclude High-Grade Squamous Intraepithelial Lesion.
    Ryu KJ, Lee S, Min KJ, Kim JW, Hong JH, Song JY, Lee JK, Lee NW.
    Oncologist; 2015 Jun 26; 20(6):635-9. PubMed ID: 25964305
    [Abstract] [Full Text] [Related]

  • 15. Correlation of histopathologic/cytologic follow-up findings with vaginal ASC-US and ASC-H Papanicolaou test and HPV test results.
    Bansal M, Li Z, Zhao C.
    Am J Clin Pathol; 2012 Mar 26; 137(3):437-43. PubMed ID: 22338056
    [Abstract] [Full Text] [Related]

  • 16. Clinical utility of adjunctive high-risk human papillomavirus DNA testing in women with Papanicolaou test findings of atypical glandular cells.
    Zhao C, Florea A, Austin RM.
    Arch Pathol Lab Med; 2010 Jan 26; 134(1):103-8. PubMed ID: 20073612
    [Abstract] [Full Text] [Related]

  • 17. Low-grade squamous intraepithelial lesion/cannot exclude high-grade squamous intraepithelial lesion (LSIL-H) is a unique category of cytologic abnormality associated with distinctive HPV and histopathologic CIN 2+ detection rates.
    Barron S, Li Z, Austin RM, Zhao C.
    Am J Clin Pathol; 2014 Feb 26; 141(2):239-46. PubMed ID: 24436272
    [Abstract] [Full Text] [Related]

  • 18. Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia.
    Arbyn M, Buntinx F, Van Ranst M, Paraskevaidis E, Martin-Hirsch P, Dillner J.
    J Natl Cancer Inst; 2004 Feb 18; 96(4):280-93. PubMed ID: 14970277
    [Abstract] [Full Text] [Related]

  • 19. Human papillomavirus test with cytology triage in organized screening for cervical cancer.
    Veijalainen O, Kares S, Kujala P, Tirkkonen M, Vuento R, Kholová I, Luukkaala T, Osuala V, Mäenpää J.
    Acta Obstet Gynecol Scand; 2016 Nov 18; 95(11):1220-1227. PubMed ID: 27591407
    [Abstract] [Full Text] [Related]

  • 20. Contribution of human papillomavirus testing by hybrid capture in the triage of women with repeated abnormal pap smears before colposcopy referral.
    Fait G, Kupferminc MJ, Daniel Y, Geva E, Ron IG, Lessing JB, Bar-Am A.
    Gynecol Oncol; 2000 Nov 18; 79(2):177-80. PubMed ID: 11063640
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.